Sybron Redux Launches

Credit Suisse and Bank of America are in the market with a $250 million deal for Sybron Dental Specialties.

  • 10 Mar 2006
Email a colleague
Request a PDF

Credit Suisse and Bank of America are in the market with a $250 million deal for Sybron Dental Specialties. The loan, which refinances a previous credit, is a five-year, $250 million revolving credit facility. Pricing on the revolver is LIBOR plus 62.5 basis points. The deal launched on March 2.

The previous $350 million deal, which launched in May 2002, comprised a five-year, $250 million revolver and a seven-year, $200 million term loan "B." Pricing on the revolver was LIBOR plus 2 1/4% and LIBOR plus 2 3/4% on the "B" tranche.

Moody's Investors Service assigned a Ba2 rating to the deal while Standard & Poor's assigned a BB+ rating. Based in Newport Beach, Calif., Sybron is a manufacturer of dental implants and infection prevention products. Their clients include the dental and orthodontic industries. A spokesman at Sybron declined comment as did bankers at B of A. A call to Credit Suisse was not returned.

  • 10 Mar 2006

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 BNP Paribas 15,256 32 16.83
2 Bank of America Merrill Lynch (BAML) 10,179 30 11.23
3 Citi 9,751 23 10.76
4 Lloyds Bank 7,329 24 8.09
5 JP Morgan 6,580 10 7.26

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 RBC Capital Markets 801.51 2 13.30%
2 Citi 783.55 4 13.01%
3 Wells Fargo Securities 606.78 3 10.07%
4 Credit Suisse 534.82 2 8.88%
5 SG Corporate & Investment Banking 497.64 2 8.26%